FKBP1AP3

Across TCGA pan-cancer cohorts, FKBP1AP3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FKBP1AP3’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where FKBP1AP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FKBP1AP3 is over-expressed in tumor.

STAD and LUSC are the cancer types where FKBP1AP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FKBP1AP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	IV	+0.310	.027	1	view →
LUSC	Female	III,IV	+0.290	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

FKBP1AP3–STAD

Open the STAD breakdown →